LB-102 for the Treatment of Acutely Exacerbated Schizophrenia: Insights From the Principal Investigator
Psychiatric Times
MARCH 31, 2025
In this exclusive interview with Psychiatric Times, John Kane, MD, shares more on the new positive data on LB-102 for the treatment of acutely exacerbated schizophrenia.
Let's personalize your content